Copeptin During a Standardized Psychological Stress Test (PsyCo)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01866137
First received: May 13, 2013
Last updated: May 23, 2014
Last verified: May 2014
  Purpose

The aim of the PsyCo Study is to determine whether psychological Stress has an influence on copeptin levels.


Condition
Stress

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Copeptin During a Standardized Psychological Stress Test

Resource links provided by NLM:


Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Changes in copeptin levels after a psychological stress test [ Time Frame: 30min before, at time point 0, +10, +20, +40, +60 after the psychological stress test ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

7.5 ml of EDTA blood, 7.5 ml of serum


Enrollment: 20
Study Start Date: March 2013
Study Completion Date: February 2014
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Groups/Cohorts
no treatment
no treatment

Detailed Description:

healthy volunteers undergo the TSST and stress hormones as cortisol and copeptin are measured

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

healthy adults

Criteria

Inclusion Criteria:

•Aged over 18 years

Exclusion Criteria:

  • Intake of any kind of medication (except birth control pill)
  • BMI >30 kg/m2
  • Evidence of any acute illness
  • History of chronic illness
  • Baseline glucose level >7 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01866137

Locations
Switzerland
University Hospital Basel
Basel, Basel-Stadt, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Principal Investigator: Mirjam Christ-Crain, Prof.Dr.med.
  More Information

No publications provided

Responsible Party: University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01866137     History of Changes
Other Study ID Numbers: PsyCo
Study First Received: May 13, 2013
Last Updated: May 23, 2014
Health Authority: Switzerland: Swissmedic

Keywords provided by University Hospital, Basel, Switzerland:
Copeptin
psychological stress
The Trier Social Stress Test (TSST)

Additional relevant MeSH terms:
Stress, Psychological
Behavioral Symptoms

ClinicalTrials.gov processed this record on July 20, 2014